| Literature DB >> 25537754 |
J Matowo1, J Kitau, R Kaaya, R Kavishe, A Wright, W Kisinza, I Kleinschmidt, F Mosha, M Rowland, N Protopopoff.
Abstract
Anopheles gambiae s.l. (Diptera: Culicidae) in Muleba, Tanzania has developed high levels of resistance to most insecticides currently advocated for malaria control. The kdr mutation has almost reached fixation in An. gambiae s.s. in Muleba. This change has the potential to jeopardize malaria control interventions carried out in the region. Trends in insecticide resistance were monitored in two intervention villages using World Health Organization (WHO) susceptibility test kits. Additional mechanisms contributing to observed phenotypic resistance were investigated using Centers for Disease Control (CDC) bottle bioassays with piperonylbutoxide (PBO) and S,S,S-tributyl phosphorotrithioate (DEF) synergists. Resistance genotyping for kdr and Ace-1 alleles was conducted using quantitative polymerase chain reaction (qPCR). In both study villages, high phenotypic resistance to several pyrethroids and DDT was observed, with mortality in the range of 12-23%. There was a sharp decrease in mortality in An. gambiae s.l. exposed to bendiocarb (carbamate) from 84% in November 2011 to 31% in December 2012 after two rounds of bendiocarb-based indoor residual spraying (IRS). Anopheles gambiae s.l. remained susceptible to pirimiphos-methyl (organophosphate). Bendiocarb-based IRS did not lead to the reversion of pyrethroid resistance. There was no evidence for selection for Ace-1 resistance alleles. The need to investigate the operational impact of the observed resistance selection on the effectiveness of longlasting insecticidal nets and IRS for malaria control is urgent.Entities:
Keywords: Ace-1; bendiocarb; bioassays; carbamate; kdr; mutation; organophosphate; synergists
Mesh:
Substances:
Year: 2014 PMID: 25537754 PMCID: PMC4359020 DOI: 10.1111/mve.12090
Source DB: PubMed Journal: Med Vet Entomol ISSN: 0269-283X Impact factor: 2.739
Figure 1The map of Muleba District, in northwest Tanzania, showing the study sites at Kiteme and Kyamyorwa villages.
Figure 2Trends in the resistance status of populations in the two villages exposed to bendiocarb and lambdacyhalothrin in May and November in 2011 and 2012. No susceptibility tests were conducted in the village supplied with longlasting insecticidal nets (LLINs) in May 2011. IRS, indoor residual spraying.
Mortality rates in populations sampled from the two villages in the longlasting insecticidal nets (LLINs) only and the LLINs with indoor residual spraying (IRS) arms of the intervention in response to diagnostic concentrations of permethrin, deltamethrin, lambdacyhalothrin, DDT, bendiocarb and pirimiphos‐methyl in World Health Organization (WHO) susceptibility tests
| Number exposed (% mortality) | ||||||
|---|---|---|---|---|---|---|
| Kiteme (LLINs only) | Kyamyorwa (LLINs + IRS) | |||||
| Insecticide | November 2011 | May 2012 | December 2012 | November 2011 | May 2012 | December 2012 |
| DDT | 85 (40%) | 104 (18%) | — | 99 (13%) | 95 (13%) | — |
| Permethrin | 98 (11%) | 101 (22%) | — | — | 119 (15%) | — |
| Deltamethrin | — | 99 (22%) | — | — | 82 (34%) | — |
| Lambdacyhalothrin | 104 (31%) | 159 (23%) | 75 (17%) | 232 (22%) | 183 (12%) | 29 (14%) |
| Bendiocarb | 84 (91%) | 161 (88%) | 114 (86%) | 175 (84%) | 325 (76%) | 52 (31%) |
| Pirimiphos methyl | — | 10 (100%) | — | — | 101 (100%) | — |
Figure 3Percentage knock‐down over time for an F1 generation of wild‐caught mosquitoes exposed to permethrin alone, permethrin + piperonylbutoxide (PBO), permethrin + S,S,S‐tributyl phosphorotrithioate (DEF), and permethrin + PBO + DEF relative to a permethrin test of a susceptible mosquito strain (Kisumu) in Centers for Disease Control (CDC) bottle bioassays.
Synergy tests for (F1) from Muleba relative to the standard susceptible strain (Kisumu) in Centers for Disease Control (CDC) bottle bioassays
| Mortality, % ( | KdT50, min (95% CI) | ||||
|---|---|---|---|---|---|
| Treatment | F1 wild progeny | Susceptible strain | F1 wild progeny | Susceptible strain | KdT50 ratio |
| Permethrin alone | 17.8% (107) | 100% (118) | 62.9 (59.6–67.4) | 11.6 (10.7–12.4) | 5.4 |
| Permethrin + DEF | 83.2% (107) | 100% (95) | 28.1 (27.0–29.1) | 8.5 (6.7–10.2) | 3.3 |
| Permethrin + PBO | 93.5% (108) | 100% (107) | 28.9 (28.1–29.7) | 10.3 (9.8–10.8) | 2.8 |
| Permethrin + PBO + DEF | 96.6% (92) | 100% (98) | 34.8 (33.8–35.9) | 10.0 (9.5–10.4) | 3.5 |
PBO, piperonylbutoxide; DEF, S,S,S‐tributyl phosphorotrithioate.